| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.69M | $ 13.04M | $ 3.22M | $ 7.20M | $ 16.00M |
| Gross Profit | $ 11.11M | $ 6.27M | $ -2.07M | $ -4.58M | $ 448.98K |
| Operating Income | $ 1.37M | $ -1.41M | $ -12.52M | $ -17.20M | $ -15.70M |
| EBITDA | $ 1.45M | $ -310.14K | $ -1.26M | $ -8.41M | $ -24.06M |
| Net Income | $ -7.73M | $ -3.29M | $ 5.61M | $ -18.34M | $ -48.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 49.02K | $ 499.47K | $ 724.52K | $ 25.35K | $ 16.93K |
| Total Assets | $ 20.25M | $ 20.57M | $ 19.63M | $ 12.26M | $ 14.71M |
| Total Debt | $ 11.78M | $ 15.11M | $ 16.06M | $ 22.02M | $ 50.22M |
| Net Debt | $ 11.73M | $ 14.61M | $ 15.33M | $ 22.00M | $ 50.20M |
| Total Liabilities | $ 57.10M | $ 49.67M | $ 46.94M | $ 61.28M | $ 83.58M |
| Stockholders' Equity | $ -36.82M | $ -29.09M | $ -27.30M | $ -49.02M | $ -68.87M |
| Cash Flow | |||||
| Free Cash Flow | $ 3.04M | $ -253.58K | $ -8.91M | $ -17.30M | $ -13.53M |
| Operating Cash Flow | $ 3.39M | $ -218.35K | $ -8.91M | $ -16.93M | $ -13.53M |
| Investing Cash Flow | $ -1.53M | $ -905.19K | $ -374.47K | $ -288.89K | $ -658.66K |
| Financing Cash Flow | $ -2.31M | $ 898.49K | $ 9.99M | $ 17.23M | $ 14.20M |
Rennova Health (RNVA)
OTHER OTC:RNVA
